Pregnancy in Patients with a History of Spontaneous Coronary Artery Dissection (SCAD)

Size: px
Start display at page:

Download "Pregnancy in Patients with a History of Spontaneous Coronary Artery Dissection (SCAD)"

Transcription

1 Pregnancy in Patients with a History of Spontaneous Coronary Artery Dissection (SCAD) Marysia Tweet, MD The 4 th International Congress on Cardiac Problems in Pregnancy February 29 th, MFMER slide-1

2 Overview Basics of spontaneous coronary artery dissection (SCAD) Postpartum SCAD Pregnancy following SCAD 2015 MFMER slide-2

3 Spontaneous coronary artery dissection (SCAD) Acute coronary syndrome without atherosclerosis Intramural hematoma +/- intimal disruption Diagnosed via: * Coronary angio IVUS OCT * * 2015 MFMER slide-3

4 2015 MFMER slide-4

5 39 yo G6P4 Woman 5 days postpartum Chest pain ECG negative at urgent care 8 days postpartum Recurrent CP ECG negative, CT PE negative 13 days postpartum Severe 10/10 CP EMS called, v fib arrest Resuscitated 2015 MFMER slide-5

6 2015 MFMER slide-6

7 2015 MFMER slide-8

8 Recurrent CP 2015 MFMER slide-9

9 2015 MFMER slide-10

10 2015 MFMER slide-11

11 2015 MFMER slide-12

12 * 2015 MFMER slide-13

13 Cardiac MRI 2015 MFMER slide-14

14 Case 2: 42 yo F with V. Fib Arrest 2015 MFMER slide-15

15 Optical coherence tomography (OCT) 2015 MFMER slide-16

16 Intramural hematoma on OCT * * 2015 MFMER slide-17

17 Conservatively managed, Healing on follow-up 2015 MFMER slide-18

18 SCAD Reported prevalence % Prevalence likely higher due to awareness and improved diagnostic techniques Cause of MI in 10-30% F <50 yo Likely most common etiology of MI during or shortly after pregnancy ~18% of SCAD is peripartum Tweet et al. Circ 2012 Vanzetto et al. Cardiothorac Surg 2009 Mortensen et al. Cardiovasc Interv 2009 Saw et al. Can Jour of Cardiol 2014 Elkayam et al. Circ MFMER slide-19

19 SCAD Baseline Characteristics Mostly female Young (mean yrs) Minimal CAD risk factors Potential risk factors: fibromuscular dysplasia, postpartum/pregnancy, extreme emotion or exercise, connective tissue disease, coronary tortuosity, family history Tweet et al., Circulation 2012 Saw et al, Circ Cardiovasc Interv MFMER slide-20

20 Survival free of MACE (%) Long-Term Outcomes Major Adverse Cardiac Events Major Adverse Cardiac Events (MACE)= Death, Recurrent SCAD, MI, CHF Years after index event No. at risk Tweet et al., Circulation MFMER slide-21

21 SCAD Angiographic Subtypes Type 1: Staining in the arterial wall Type 2: Diffuse narrowing Type 3: Mimics atherosclerosis Type 1 Saw, Catheter Cardiovasc Interv MFMER slide-22

22 Type 2 Type 3 * * * * * Saw, Catheter Cardiovasc Interv MFMER slide-23

23 2011 MFMER MFMER slide-25

24 Mayo Clinic SCAD Registry & DNA Biorepository North America 2015 MFMER slide-26

25 Mayo Clinic SCAD Registry & DNA Biorepository World >500 Confirmed SCAD Patients 2015 MFMER slide-27

26 MFMER slide-28

27 SCAD Acute Management Retrospective review (N = 189) Treated with balloon and/or stent(s): Failure 53% failure to cross lesion (7/23) Final 50% loss failure of flow in those (8/23) with preserved distal Residual coronary stenosis flow, 6 (13%) >30% (8/23) emergency CABG Conservative therapy: Uneventful hospital course 73% of 59 with repeat CA showed healing 9 (10%) early SCAD progression requiring stent or bypass surgery (mean 4 days, 2-7) Tweet et al., Circ Cardiovasc Interv MFMER slide-29

28 Free of recurrent SCAD (%) Free of recurrent SCAD (%) Free of target vessel revascularization (%) Free of target vessel revascularization (%) Comparison of Long-Term Outcomes According to Initial Treatment Strategy and Presenting Vessel Flow Revascularization vs Conservative Management 100 Conservative 80 Target Vessel Revascularization Target Vessel Revascularization PF-PCI vs PF-Con PF-Con 60 Revascularization 60 PF-PCI P= Years No. at risk P= Years No. at risk Revascularization vs Conservative Management 100 Revascularization 80 Recurrent SCAD Recurrent SCAD PF-PCI vs PF-Con PF-PCI Conservative PF-Con 20 P= P= Years Years No. at risk No. at risk Tweet et al., Circ Cardiovasc Interv, MFMER slide-30

29 Proposed Algorithm for Acute Management of Initial SCAD Acute SCAD on angiography No Yes OCT/IVUS: False lumen or intramural hematoma? Yes TIMI flow assessment TIMI 0-1 or clinically unstable TIMI 2-3 and clinically stable Revascularize with inpatient monitoring for 5-7 days, consider CABG in high volume surgical centers Conservative management with inpatient monitoring for 5-7 days Tweet et al., Circ Cardiovasc Interv, MFMER slide-33

30 SCAD Coronary Tortuosity SCAD Control 246 Mayo Clinic SCAD Registry patients vs 313 controls Mean age 45 yrs 96% women Eleid et al., Circ Cardiovasc Interv MFMER slide-34

31 Prevalence of SCAD Coronary Tortuosity 70% 60% P< for all 50% 40% 30% 20% SCAD (N=246) Controls (N=313) 10% 0% LAD tortuosity LCX tortuosity RCA tortuosity Eleid et al., Circ Cardiovasc Interv MFMER slide-35

32 SCAD Coronary Tortuosity Recurrent SCAD (n=40) occurred within segments of tortuosity in 80% High recurrence risk if severe tortuosity Arterial abnormalities and FMD associated with corkscrew and multivessel symmetrical tortuosity (P<0.05 for both) Eleid et al., Circ Cardiovasc Interv MFMER slide-36

33 SCAD and Vascular Abnormalities 115 Mayo Clinic SCAD outpatients Overall Vascular Abnormalities 66% Vascular abnormalities: Overall Fibromuscular FMD 45% dysplasia Dissection Aneurysm Dilatation Tortuosity Undulating aorta Prasad et al., Am J Cardiol, MFMER slide-37

34 SCAD and Connective Tissue Disease (CTD) 116 Mayo Clinic SCAD pts evaluated in Genetics Clinic 41% with FMD 59 underwent genetic testing 3 (5.1%) diagnosed with CTD Marfan and Vascular Ehlers- Danlos Henkin et al., Heart, MFMER slide-38

35 SCAD in the Family 5 familial cases among 412 patient enrollees Mother-Daughter Identical twin sisters Sisters Aunt-niece First cousin pairs False lumen Implicates both recessive and dominant modes of inheritance Ongoing Mayo DNA biorepository Goel et al., JAMA Intern Med, MFMER slide-39

36 Number of SCAD patients Peripartum SCAD, N= Delivery = first week postpartum < mos 7-12 mos Weeks Pregnant Weeks Postpartum Months following Pregnancy Tweet et al., AHA 2015 MFMER slide-40

37 Peripartum SCAD Tweet et al., AHA 2015 MFMER slide-41

38 Pregnancy after SCAD Of 363 women, 8 pregnant after SCAD Mean age at time of MI 36+3 yrs Elapsed time to pregnancy was 18+9 mos 3/8 initially given a diagnosis of coronary vasospasm Tweet et al., Ann Intern Med MFMER slide-42

39 Pregnancy after SCAD 6 pregnancies resulted in live birth 3 vaginal deliveries 3 cesarean sections Placenta previa and antepartum hemorrhage 2 miscarriages at 9 and 15 wks Tweet et al., Ann Intern Med MFMER slide-43

40 Pregnancy after SCAD Follow-up median 36 mos 7 women without complications 1 woman with STEMI at 9 weeks postpartum Unsuccessful PCI->CABG for left main SCAD Tweet et al., Ann Intern Med MFMER slide-44

41 Initial SCAD 1 G2P2 Pregnant 35 yo Induced VD 22 mos To term 18 mos Last follow-up FMD 2 *MS G4P3 4 wks 4 mos Pregnant Miscarriage 42 yo 6.5 yrs Last follow-up Postpartum SCAD 3 G4P4 19 mos To term Pregnant 40 yo Elective C-section 2 yrs Last follow-up 4 G4P4 18 mos To term Pregnant 34 yo NSVD 2 mos 14 mos SCAD recurrence Last follow-up 5 *TIA, SM G2P2 Pregnant 36 yo Elective C-section 28 mos 34 wks 4.7 yrs Last follow-up 6 G4P4 Pregnant 36 yo Induced VD 26 mos To term 3 mos Last follow-up 7 G4P3 Pregnant 35 yo 9 mos To term Elective C-section 3 mos Last follow-up 8 *FT, MCT G3P1 23 mos Pregnant 39 yo 6 wks Miscarriage 3.6 yrs Last follow-up D&C = dilation and curettage; FMD = fibromuscular dysplasia; FT= fertility treatment history; G = Gravida; NSVD = normal spontaneous vaginal delivery; mos = months; MCT=mixed connective tissue disease; MS = multiple sclerosis; P = para; SCAD = spontaneous coronary artery dissection; SM=systemic mastocytosis; TIA=transient ischemic attack; VD = vaginal delivery Tweet et al., Ann Intern Med MFMER slide-45

42 Pregnancy after SCAD Advised to avoid pregnancy Advised against systemic hormonal contraception Should a patient decide to pursue pregnancy, recommend care by cardiology and maternal fetal medicine team Tweet et al., Ann Intern Med MFMER slide-46

43 Other Considerations Recommend cardiac rehab Assess for anxiety and depression 2015 MFMER slide-47

44 Thank you! Questions & Discussion 2015 MFMER slide-48

Multimodality Imaging in Spontaneous Coronary Artery Dissection in the Peripartum Period

Multimodality Imaging in Spontaneous Coronary Artery Dissection in the Peripartum Period Multimodality Imaging in Spontaneous Coronary Artery Dissection in the Peripartum Period Marysia Tweet, MD NASCI Annual Meeting October 18 th, 2016 2016 MFMER slide-1 DISCLOSURE No relevant financial relationship(s)

More information

More about Spontaneous Coronary Artery Dissection (SCAD): Outpatient Management

More about Spontaneous Coronary Artery Dissection (SCAD): Outpatient Management More about Spontaneous Coronary Artery Dissection (SCAD): Outpatient Management Matters of the Heart 7 th Annual Women s Heart Conference February 10, 2017 Marysia Tweet, MD, FACC 2016 MFMER 3537671-1

More information

What is Spontaneous Coronary Artery Dissection (SCAD) & Why is Cardiac Rehabilitation Important?

What is Spontaneous Coronary Artery Dissection (SCAD) & Why is Cardiac Rehabilitation Important? What is Spontaneous Coronary Artery Dissection (SCAD) & Why is Cardiac Rehabilitation Important? Marysia Tweet, MD 25 th Annual MNACVPR State Conference October 3 rd, 2015 2015 MFMER slide-1 Goals: Learn

More information

Spontaneous Coronary Artery Dissection

Spontaneous Coronary Artery Dissection Spontaneous Coronary Artery Dissection Malissa J. Wood, MD FACC FAHA Co-Director MGH Heart Center Corrigan Women s Heart Health Program Massachusetts General Hospital 40 y/o female transferred from OSH

More information

Coronary Artery Manifestations of Fibromuscular Dysplasia: Infrequent and Easily Missed

Coronary Artery Manifestations of Fibromuscular Dysplasia: Infrequent and Easily Missed Coronary Artery Manifestations of Fibromuscular Dysplasia: Infrequent and Easily Missed Jeffrey W Olin, D.O., F.A.C.C., F.A.H.A. Professor of Medicine (Cardiology) Director of Vascular Medicine & Vascular

More information

Case Presentation: STEMI. Jennifer A. Tremmel, MD, MS Stanford University Medical Center SCAI Fall Fellow s Course 2015

Case Presentation: STEMI. Jennifer A. Tremmel, MD, MS Stanford University Medical Center SCAI Fall Fellow s Course 2015 Case Presentation: STEMI Jennifer A. Tremmel, MD, MS Stanford University Medical Center SCAI Fall Fellow s Course 2015 STEMI 42 yo woman with no cardiac risk factors presents with chest pain radiating

More information

Women and Ischemic Heart Disease Lessons Learned

Women and Ischemic Heart Disease Lessons Learned Women and Ischemic Heart Disease 2017- Lessons Learned Bina Ahmed MD Interventional Cardiology Dartmouth-Hitchcock Medical Center Assistant Professor of Medicine Geisel School of Medicine Lebanon, NH ba@hitchcock.org

More information

Anthony Main 1, William L. Lombardi 2, Jacqueline Saw 3. Introduction. Case presentation

Anthony Main 1, William L. Lombardi 2, Jacqueline Saw 3. Introduction. Case presentation Case Report Cutting balloon angioplasty for treatment of spontaneous coronary artery dissection: case report, literature review, and recommended technical approaches Anthony Main 1, William L. Lombardi

More information

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell

More information

Lessons learned From The National PCI Registry

Lessons learned From The National PCI Registry Lessons learned From The National PCI Registry w a v e On Behalf of The Publication Committee of the National PCI Registry Objectives & Anticipated Achievements To determine the epidemiology of patients

More information

LM stenting - Cypher

LM stenting - Cypher LM stenting - Cypher Left main stenting with BMS Since 1995 Issues in BMS era AMC Restenosis and TLR (%) 3 27 TLR P=.282 Restenosis P=.71 28 2 1 15 12 Ostium 5 4 Shaft Bifurcation Left main stenting with

More information

Recurrent Spontaneous Coronary Artery Dissection in a Patient with Fibromuscular Dysplasia

Recurrent Spontaneous Coronary Artery Dissection in a Patient with Fibromuscular Dysplasia Recurrent Spontaneous Coronary Artery Dissection in a Patient with Fibromuscular Dysplasia Craig Basman, MD; Tannaz Shoja, MD; Aditya Mangla, DO; Jaffar Raza, MD; Suresh Jain, MD; Zoran Lasic, MD Clinical

More information

Current Role of Renal Artery Stenting in Patients with Renal Artery Stenosis

Current Role of Renal Artery Stenting in Patients with Renal Artery Stenosis Current Role of Renal Artery Stenting in Patients with Renal Artery Stenosis Young-Guk Ko, M.D. Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea Etiology Fibromuscular

More information

The SYNTAX-LE MANS Study

The SYNTAX-LE MANS Study The SYNTAX-LE MANS Study Synergy Between PCI with TAXUS Express and Cardiac Surgery: Late (15-month) Left Main Angiographic Substudy A. Pieter Kappetein, MD, PhD Erasmus MC, Rotterdam, NL SYNTAX-LE MANS

More information

Post PCI functional testing and imaging: case based lessons from FFR React

Post PCI functional testing and imaging: case based lessons from FFR React Post PCI functional testing and imaging: case based lessons from FFR React Joost Daemen, MD, PhD, FESC Optics in Cardiology 2018 April 21st, 2018 10.15 10.30h Disclosure Statement of Financial Interest

More information

FFR in Multivessel Disease

FFR in Multivessel Disease FFR in Multivessel Disease April, 26 2013 Coronary Physiology in the Catheterization Laboratory Location: European Heart House, Nice, France Pim A.L. Tonino, MD, PhD Hartcentrum, Eindhoven, the Netherlands

More information

Intervention: How and to which extent is technology helping us?

Intervention: How and to which extent is technology helping us? Cardiological Society of India Congress 12th February 2016 Chennai, India Intervention: How and to which extent is technology helping us? SIMONE BISCAGLIA MD CARDIOVASCULAR INSTITUTE, FERRARA, ITALY Introduction

More information

Bifurcation stenting with BVS

Bifurcation stenting with BVS Bifurcation stenting with BVS Breaking the limits or just breaking the struts? Maciej Lesiak Department of Cardiology University Hospital in Poznan, Poland Disclosure Speaker s name: Maciej Lesiak I have

More information

Spontaneous Coronary Artery Dissection

Spontaneous Coronary Artery Dissection Spontaneous Coronary Artery Dissection Esther S.H. Kim, MD, MPH Director, Arteriopathy Clinic Associate Professor of Medicine Vanderbilt University Medical Center April 18, 2018 No Disclosures Patient

More information

Clinical characteristics and long-term prognosis of spontaneous coronary artery dissection: A single-center Chinese experience

Clinical characteristics and long-term prognosis of spontaneous coronary artery dissection: A single-center Chinese experience Original Article Clinical characteristics and long-term prognosis of spontaneous coronary artery dissection: A single-center Chinese experience Xintian Liu 1, Chengyi Xu 2, Chengwei Liu 3, Xi Su 4 ABSTRACT

More information

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome

Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome Surgical vs. Percutaneous Revascularization in Patients with Diabetes and Acute Coronary Syndrome Chris C. Cook, MD Associate Professor of Surgery Director, CT Residency Program, WVU ACOI 10/17/18 No Disclosures

More information

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki Hong, MD. PhD on behalf of the IVUS-XPL trial investigators

More information

When Aspiration Thrombectomy Does Not Work? A A R O N W O N G N A T I O N A L H E A R T C E N T R E S I N G A P O R E

When Aspiration Thrombectomy Does Not Work? A A R O N W O N G N A T I O N A L H E A R T C E N T R E S I N G A P O R E When Aspiration Thrombectomy Does Not Work? A A R O N W O N G N A T I O N A L H E A R T C E N T R E S I N G A P O R E Thrombus in STEMI Over 70% of STEMI patients has angiographic evidence of thrombus

More information

Coronary interventions

Coronary interventions Controversial issues in the management of ischemic heart failure Coronary interventions Maciej Lesiak Department of Cardiology, University Hospital in Poznan none DECLARATION OF CONFLICT OF INTEREST CHF

More information

Coronary stenting: the appropriate use of FFR

Coronary stenting: the appropriate use of FFR Coronary stenting: the appropriate use of FFR Morton J. Kern, MD Professor of Medicine Chief of Cardiology LBVA Associate Chief Cardiology University California Irvine Orange, California To treat or not

More information

Benefit of Performing PCI Based on FFR

Benefit of Performing PCI Based on FFR Benefit of Performing PCI Based on FFR William F. Fearon, MD Associate Professor Director, Interventional Cardiology Stanford University Medical Center Benefit of FFR-Guided PCI FFR-Guided PCI vs. Angiography-Guided

More information

Acute Coronary Syndrome. Sonny Achtchi, DO

Acute Coronary Syndrome. Sonny Achtchi, DO Acute Coronary Syndrome Sonny Achtchi, DO Objectives Understand evidence based and practice based treatments for stabilization and initial management of ACS Become familiar with ACS risk stratification

More information

EAE Teaching Course. Magnetic Resonance Imaging. Competitive or Complementary? Sofia, Bulgaria, 5-7 April F.E. Rademakers

EAE Teaching Course. Magnetic Resonance Imaging. Competitive or Complementary? Sofia, Bulgaria, 5-7 April F.E. Rademakers EAE Teaching Course Magnetic Resonance Imaging Competitive or Complementary? Sofia, Bulgaria, 5-7 April 2012 F.E. Rademakers Complementary? Of Course N Engl J Med 2012;366:54-63 Clinical relevance Treatment

More information

PCI for Long Coronary Lesion

PCI for Long Coronary Lesion PCI for Long Coronary Lesion Shift of a General Idea with the Introduction of DES In the Bare Metal Stent Era Higher Restenosis Rate With Increasing Stent Length and Decreasing Stent Area Restenosis.6.4.2

More information

DEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea.

DEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea. DEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea. In-stent restenosis (ISR) Remains important issue even in the

More information

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions Julinda Mehilli, MD Deutsches Herzzentrum Technische Universität Munich Germany ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions Background Left main

More information

Out-of-hospital Cardiac Arrest. Franz R. Eberli MD, FESC, FAHA Cardiology Triemli Hospital Zurich, Switzerland

Out-of-hospital Cardiac Arrest. Franz R. Eberli MD, FESC, FAHA Cardiology Triemli Hospital Zurich, Switzerland Out-of-hospital Cardiac Arrest Franz R. Eberli MD, FESC, FAHA Cardiology Triemli Hospital Zurich, Switzerland Conflict of Interest I have no conflict of interest to disclose regarding this presentation.

More information

Case Report Extension of a Coronary Intramural Hematoma as a Complication of Early Percutaneous Coronary Intervention after Thrombolytic Therapy

Case Report Extension of a Coronary Intramural Hematoma as a Complication of Early Percutaneous Coronary Intervention after Thrombolytic Therapy Case Reports in Medicine Volume 2013, Article ID 218389, 4 pages http://dx.doi.org/10.1155/2013/218389 Case Report Extension of a Coronary Intramural Hematoma as a Complication of Early Percutaneous Coronary

More information

Euro-Asia CTO Club Can we Implement Japanese Techniques in Europe?

Euro-Asia CTO Club Can we Implement Japanese Techniques in Europe? Euro-Asia CTO Club Can we Implement Japanese Techniques in Europe? T. Lefèvre,, Massy, France Background Despite continuous improvement, PTCA of chronic total occlusion remains a real technical challenge.

More information

NON-ATHEROSCLEROTIC PATHOLOGY OF THE CAROTID ARTERIES

NON-ATHEROSCLEROTIC PATHOLOGY OF THE CAROTID ARTERIES NON-ATHEROSCLEROTIC PATHOLOGY OF THE CAROTID ARTERIES Leslie M. Scoutt, MD, FACR Professor of Diagnostic Radiology & Surgery Vice Chair, Dept of Radiology & Biomedical Imaging Chief, Ultrasound Section

More information

Pregnancy in Marfan Syndrome and Bicuspid Aortic Valve Related Aortopathy

Pregnancy in Marfan Syndrome and Bicuspid Aortic Valve Related Aortopathy Pregnancy in Marfan Syndrome and Bicuspid Aortic Valve Related Aortopathy Heidi M. Connolly, MD Cardiac Problems in Pregnancy Venice Italy, February 2014 No Disclosures 2012 MFMER slide-1 Regitz-Zagrosek

More information

Coronary artery Dissection. Dr TP Singh MD,DM

Coronary artery Dissection. Dr TP Singh MD,DM Coronary artery Dissection Dr TP Singh MD,DM 52 M,Non HT, Non DM,Acute IWMI lysed within 4 hours D2 Coronary angiography RCA mid 90% discrete hazy stenosis LAD non significant ifi disease, LCx Normal Taken

More information

Clinical case in perspective. Cases from Poland

Clinical case in perspective. Cases from Poland Clinical case in perspective Cases from Poland Assoc. Prof. Jacek Legutko, MD, PhD President-Elect of the Association for Percutaneous Cardiovascular Interventions of the Polish Cardiac Society Institute

More information

Our Million Dollar Man

Our Million Dollar Man Our Million Dollar Man Paul Myers = $25M LGH Foundation = $75M Province/VCH = $100M Total Project Cost = $200M Paul Myers Acute Care Tower New Medical & Surgical Centre Single Patient Rooms New State-of-the-Art

More information

Why I try to avoid side branch dilatation

Why I try to avoid side branch dilatation Why I try to avoid side branch dilatation Hyeon-Cheol Gwon Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Why I don t kiss? I kiss! I prefer to discuss SB ballooning rather

More information

Subclavian artery Stenting

Subclavian artery Stenting Subclavian artery Stenting Etiology Atherosclerosis Takayasu s arteritis Fibromuscular dysplasia Giant Cell Arteritis Radiation-induced Vascular Injury Thoracic Outlet Syndrome Neurofibromatosis Incidence

More information

Integrated Use of IVUS and FFR for LM Stenting

Integrated Use of IVUS and FFR for LM Stenting Integrated Use of IVUS and FFR for LM Stenting Gary S. Mintz, MD Cardiovascular Research Foundation Four studies have highlighted the inaccuracy of angiography in the assessment of LMCA disease Fisher

More information

Patient. Clinical data Indications: Operation date. Comorbidities: Patient code Birth date: / /

Patient. Clinical data Indications: Operation date. Comorbidities: Patient code Birth date: / / Patient Patient code Birth date: / / Sex: Male Height (cm): Female Weight (kg): Risk Factors: Family history of coronary disease: Hypertension Dyslipidemia Peripheral disease Diabetes Comorbidities: No

More information

Spontaneous Coronary Artery Dissection: A Case Series of 9 Patients With Literature Review

Spontaneous Coronary Artery Dissection: A Case Series of 9 Patients With Literature Review 770479HICXXX10.1177/2324709618770479Journal of Investigative Medicine High Impact Case ReportsGhani et al case-report20182018 Case Report Spontaneous Coronary Artery Dissection: A Case Series of 9 Patients

More information

Form 4: Coronary Evaluation

Form 4: Coronary Evaluation Patient Details Hidden Show Show/Hide Annotations Form : Coronary Evaluation Print this Form t Started Date of Coronary Evaluation Coronary Evaluation Indication for Coronary Evaluation Check only one.

More information

Percutaneous Intervention of Unprotected Left Main Disease

Percutaneous Intervention of Unprotected Left Main Disease Percutaneous Intervention of Unprotected Left Main Disease Technical feasibility and Clinical outcomes Seung-Jung Park, MD, PhD, FACC Professor of Internal Medicine Asan Medical Center, Seoul, Korea Unprotected

More information

PCI for In-Stent Restenosis. CardioVascular Research Foundation

PCI for In-Stent Restenosis. CardioVascular Research Foundation PCI for In-Stent Restenosis ISR of BMS Patterns of In-Stent Restenosis Pattern I : Focal Type IA: Articulation / Gap Type IB: Marginal Type IC: Focal body Type ID: Multifocal Pattern II,III,IV : Diffuse

More information

Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI

Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI Target vessel only revascularization versus complet revascularization in non culprit lesions in acute myocardial infarction treated by primary PCI Gamal Abdelhady, Emad Mahmoud Department of interventional

More information

Left Main Intervention: Will it become standard of care?

Left Main Intervention: Will it become standard of care? Left Main Intervention: Will it become standard of care? David Cox, MD FSCAI, FACC Director, Interventional Cardiology Research Associate Director, Cardiac Cath Lab Lehigh Valley Health Network Allentown,

More information

Form 4: Coronary Evaluation

Form 4: Coronary Evaluation Form : Coronary Evaluation Print this Form t Started Date of Coronary Evaluation Coronary Evaluation Indication for Coronary Evaluation Check only one. Angio NOT DONE: n invasive test performed Followup

More information

Fractional Flow Reserve: Basics, FAME 1, FAME 2. William F. Fearon, MD Associate Professor Stanford University Medical Center

Fractional Flow Reserve: Basics, FAME 1, FAME 2. William F. Fearon, MD Associate Professor Stanford University Medical Center Fractional Flow Reserve: Basics, FAME 1, FAME 2 William F. Fearon, MD Associate Professor Stanford University Medical Center Conflict of Interest Advisory Board for HeartFlow Research grant from St. Jude

More information

Diagnostic Challenges

Diagnostic Challenges Mechanisms and Outcome of Vasospastic Angina Diagnostic Challenges Udo Sechtem Robert-Bosch-Krankenhaus Stuttgart, Germany I have nothing to disclose. Coronary spasm does it exist at all? And if it does,

More information

CASE from South Korea

CASE from South Korea CASE from South Korea Bon-Kwon Koo, MD, PhD, Seoul, Korea Outpatient clinic of a non-interventional cardiologist F/56 Chief complaint: Angina with recent aggravation, CCS II~III Brief history: # Stroke

More information

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Hein J. Verberne Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands International Conference

More information

INSIDE INFORMATION YOU CAN T IGNORE

INSIDE INFORMATION YOU CAN T IGNORE INSIDE INFORMATION YOU CAN T IGNORE Volcano, the Volcano logo and SyncVision are registered trademarks of Volcano Corporation. All other trademarks set-forth are properties of their respective owners.

More information

ROLE OF CORONARY PRESSURE & FFR IN MULTIVESSEL DISEASE

ROLE OF CORONARY PRESSURE & FFR IN MULTIVESSEL DISEASE ROLE OF CORONARY PRESSURE & FFR IN MULTIVESSEL DISEASE Angioplasty Summit TCT ASIA Seoul, Korea, april 24th, 2008 Nico H. J. Pijls, MD, PhD Catharina Hospital, Eindhoven, The Netherlands A rather common

More information

PCI for Left Anterior Descending Artery Ostial Stenosis

PCI for Left Anterior Descending Artery Ostial Stenosis PCI for Left Anterior Descending Artery Ostial Stenosis Why do you hesitate PCI for LAD ostial stenosis? LAD Ostial Lesion Limitations of PCI High elastic recoil Involvement of the distal left main coronary

More information

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO! Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO! Young-Hak Kim, MD, PhD Heart Institute, University of Ulsan College of Medicine Asan Medical Center,

More information

DECLARATION OF CONFLICT OF INTEREST

DECLARATION OF CONFLICT OF INTEREST DECLARATION OF CONFLICT OF INTEREST Multivessel disease and cardiogenic shock: CABG is the optimal revascularization therapy. Contra Prof. Christian JM Vrints Cardiogenic Shock Spiral Acute Myocardial

More information

Patient referral for elective coronary angiography: challenging the current strategy

Patient referral for elective coronary angiography: challenging the current strategy Patient referral for elective coronary angiography: challenging the current strategy M. Santos, A. Ferreira, A. P. Sousa, J. Brito, R. Calé, L. Raposo, P. Gonçalves, R. Teles, M. Almeida, M. Mendes Cardiology

More information

Left Main Intervention: Where are we in 2015?

Left Main Intervention: Where are we in 2015? Left Main Intervention: Where are we in 2015? David A. Cox, MD FSCAI Director, Cardiology Research Associate Director, Cardiac Cath Lab Lehigh Valley Health Network Allentown, PA Fall Fellows Course Laa

More information

MULTIVESSEL PCI. IN DRUG-ELUTING STENT RESTENOSIS DUE TO STENT FRACTURE, TREATED WITH REPEAT DES IMPLANTATION

MULTIVESSEL PCI. IN DRUG-ELUTING STENT RESTENOSIS DUE TO STENT FRACTURE, TREATED WITH REPEAT DES IMPLANTATION MULTIVESSEL PCI. IN DRUG-ELUTING STENT RESTENOSIS DUE TO STENT FRACTURE, TREATED WITH REPEAT DES IMPLANTATION C. Graidis, D. Dimitriadis, A. Ntatsios, V. Karasavvides Euromedica Kyanous Stavros, Thessaloniki.

More information

Mid-term results from real-world REPARA registry. Felipe Hernandez, on behalf of the REPARA investigators

Mid-term results from real-world REPARA registry. Felipe Hernandez, on behalf of the REPARA investigators Mid-term results from real-world REPARA registry Felipe Hernandez, on behalf of the REPARA investigators Potential conflicts of interest Speaker's name: Felipe Hernandez I have the following potential

More information

Optical Coherence Tomography for Intracoronary Imaging

Optical Coherence Tomography for Intracoronary Imaging Optical Coherence Tomography for Intracoronary Imaging Lorenz Räber Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical Trials Unit Bern Bern University Hospital, Switzerland

More information

Approach to Multi Vessel disease with STEMI

Approach to Multi Vessel disease with STEMI Approach to Multi Vessel disease with STEMI MANAGEMENT OF ST-ELEVATION MYOCARDIAL INFARCTION Dr. Thomas Alexander, M.D; D.M; F.A.C.C. Senior Consultant and Interventional Cardiologist Kovai Medical Centre

More information

in an Unyielding Patient Dr Jason See, Dr Goh Yew Seong, Dr Rohit Khurana Changi General Hospital Singapore

in an Unyielding Patient Dr Jason See, Dr Goh Yew Seong, Dr Rohit Khurana Changi General Hospital Singapore Unrelenting Left Main Disease in an Unyielding Patient Dr Jason See, Dr Goh Yew Seong, Dr Rohit Khurana Changi General Hospital Singapore Clinical History 72 years old Chinese lady Background and CV Risk

More information

Management of ST-elevation myocardial infarction Update 2009 Late comers: which options?

Management of ST-elevation myocardial infarction Update 2009 Late comers: which options? European Society of Cardiology Annual Session 2009 Management of ST-elevation myocardial infarction Update 2009 Late comers: which options? Antonio Abbate, MD Assistant Professor of Medicine Virginia Commonwealth

More information

Clinical Value of OCT. Guidance for Coronary Stenting. Giulio Guagliumi, MD

Clinical Value of OCT. Guidance for Coronary Stenting. Giulio Guagliumi, MD Clinical Value of OCT Guidance for Coronary Stenting Giulio Guagliumi, MD 100 % Endovascular Imaging Indications of use 87.5 % 75 % 57.5 % 50 % 45 % 25 % 15 % 0 Lesion morphology Stent optimization Lesion

More information

EBC London 2013 Provisional SB stenting strategy with kissing balloon with Absorb

EBC London 2013 Provisional SB stenting strategy with kissing balloon with Absorb EBC London 2013 Provisional SB stenting strategy with kissing balloon with Absorb A. Medina Servicio de Cardiología Hospital Universitario de Gran Canaria Dr. Negrín Islas Canarias (Spain) Provisional

More information

Detailed Order Request Checklists for Cardiology

Detailed Order Request Checklists for Cardiology Next Generation Solutions Detailed Order Request Checklists for Cardiology 8600 West Bryn Mawr Avenue South Tower Suite 800 Chicago, IL 60631 www.aimspecialtyhealth.com Appropriate.Safe.Affordable 2018

More information

Instantaneous Wave-Free Ratio

Instantaneous Wave-Free Ratio Instantaneous Wave-Free Ratio Alejandro Aquino MD Interventional Cardiology Fellow Washington University in St. Louis Barnes-Jewish Hospital Instantaneous Wave-Free Ratio Alejandro Aquino MD Disclosure

More information

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN Objectives Gain competence in evaluating chest pain Recognize features of moderate risk unstable angina Review initial management of UA and

More information

Unprotected LM intervention

Unprotected LM intervention Unprotected LM intervention Guideline for COMBAT Seung-Jung Park, MD, PhD Professor of Internal Medicine, Seoul, Korea Current Recommendation for unprotected LMCA Stenosis Class IIb C in ESC guideline

More information

FFR and intravascular imaging, which of which?

FFR and intravascular imaging, which of which? FFR and intravascular imaging, which of which? Ayman Khairy MD, PhD, FESC Associate professor of Cardiovascular Medicine Vice Director of Assiut University Hospitals Assiut, Egypt Diagnostic assessment

More information

2/26/2013. Appropriateness Use Criteria (Drilldown) Disclosures. Tony Hermann has nothing to disclose. Mark Hutcheson has nothing to disclose

2/26/2013. Appropriateness Use Criteria (Drilldown) Disclosures. Tony Hermann has nothing to disclose. Mark Hutcheson has nothing to disclose Appropriateness Use Criteria (Drilldown) Disclosures Tony Hermann has nothing to disclose Mark Hutcheson has nothing to disclose Connie Anderson has nothing to disclose Issam Moussa has nothing to disclose

More information

Stable Angina: Indication for revascularization and best medical therapy

Stable Angina: Indication for revascularization and best medical therapy Stable Angina: Indication for revascularization and best medical therapy Cardiology Basics and Updated Guideline 2018 Chang-Hwan Yoon, MD/PhD Cardiovascular Center, Department of Internal Medicine Bundang

More information

The PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque

The PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque The PROSPECT Trial Providing Regional Observations to Study Predictors of Events in the Coronary Tree A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively

More information

Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program

Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program Prof. Ran Kornowski, MD, FESC, FACC Director - Division of Interventional Cardiology Rabin Medical Center and Tel Aviv University,

More information

Prevention of Coronary Stent Thrombosis and Restenosis

Prevention of Coronary Stent Thrombosis and Restenosis Prevention of Coronary Stent Thrombosis and Restenosis Seong-Wook Park, MD, PhD, FACC Division of Cardiology, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea 9/12/03 Coronary

More information

Final Clinical and Angiographic Results From a Nationwide Registry of FIREBIRD Sirolimus- Eluting Stent: Firebird In China (FIC) Registry (PI R. Gao)

Final Clinical and Angiographic Results From a Nationwide Registry of FIREBIRD Sirolimus- Eluting Stent: Firebird In China (FIC) Registry (PI R. Gao) The Microport FIREBIRD Polymer-based Sirolimus- Eluting Stent Clinical Trial Program Update: The FIC and FIREMAN Registries Junbo Ge, MD, FACC, FESC, FSCAI On behalf of Runlin Gao (FIC PI) and Haichang

More information

Decrease cost of inpatient stay Decrease bed diversions Improve bed utilization (Interqual Criteria) Patient Satisfaction Reduce patient costs

Decrease cost of inpatient stay Decrease bed diversions Improve bed utilization (Interqual Criteria) Patient Satisfaction Reduce patient costs Decrease cost of inpatient stay Decrease bed diversions Improve bed utilization (Interqual Criteria) Patient Satisfaction Reduce patient costs (family hotel, drive back to the VA for next day pick up)

More information

Spontaneous coronary artery dissection A review

Spontaneous coronary artery dissection A review Review Article Spontaneous coronary artery dissection A review Amelia Yip, Jacqueline Saw Division of Cardiology, Vancouver General Hospital, University of British Columbia, Vancouver, BC V5Z1M9, Canada

More information

The European Consensus on Fibromuscular Dysplasia

The European Consensus on Fibromuscular Dysplasia The European Consensus on Fibromuscular Dysplasia Alexandre Persu, M.D.-PhD Cardiology Department Cliniques Universitaires Saint-Luc Catholic University of Louvain Brussels, Belgium Eur J Clin Invest.

More information

Version 4.4. Institutional Outcomes Report 2014Q3. National Outcomes Report Aggregation Date: Jan 12, :59:59 PM

Version 4.4. Institutional Outcomes Report 2014Q3. National Outcomes Report Aggregation Date: Jan 12, :59:59 PM Version 4.4 Institutional Outcomes Report 2014Q3 National Outcomes Report 999997 Aggregation Date: Jan 12, 2015 11:59:59 PM Publish Date: Jan 29, 2015 If User desires to publish or otherwise distribute

More information

Αγγειοπλαστική σε Nόσο Στελέχους: Που βρισκόμαστε. Βάιος Τζίφος Δ/ντής Τμήματος Επεμβατικής Καρδιολογίας Τομέας Καρδιάς Ερρίκος Ντυνάν Hospital Center

Αγγειοπλαστική σε Nόσο Στελέχους: Που βρισκόμαστε. Βάιος Τζίφος Δ/ντής Τμήματος Επεμβατικής Καρδιολογίας Τομέας Καρδιάς Ερρίκος Ντυνάν Hospital Center Αγγειοπλαστική σε Nόσο Στελέχους: Που βρισκόμαστε. Βάιος Τζίφος Δ/ντής Τμήματος Επεμβατικής Καρδιολογίας Τομέας Καρδιάς Ερρίκος Ντυνάν Hospital Center Δεν έχω οικονομική σχέση με φαρμακευτική εταιρία.

More information

Case 1: A 34-year-old gravida 2,

Case 1: A 34-year-old gravida 2, Clinician Update Pregnancy-Related Spontaneous Coronary Artery Dissection Ram Vijayaraghavan, MD; Subodh Verma, MD, PhD; Nandini Gupta, MD; Jacqueline Saw, MD Case 1: A 34-year-old gravida 2, para 2 woman

More information

FAME STUDY: 2-year Follow-Up & CLINICAL SUBGROUP ANALYSIS

FAME STUDY: 2-year Follow-Up & CLINICAL SUBGROUP ANALYSIS Coronary Physiology In The Cathlab FAME STUDY: 2-year Follow-Up & CLINICAL SUBGROUP ANALYSIS Educational Training Program ESC European Heart House april 7th 9th 2011 Nico H.J.Pijls, MD, PhD Catharina Hospital,

More information

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology

Cardiac evaluation for the noncardiac. Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Cardiac evaluation for the noncardiac patient Nathaen Weitzel MD University of Colorado Denver Dept of Anesthesiology Objectives! Review ACC / AHA guidelines as updated for 2009! Discuss new recommendations

More information

Percutaneous Coronary Interventions Without On-site Cardiac Surgery

Percutaneous Coronary Interventions Without On-site Cardiac Surgery Percutaneous Coronary Interventions Without On-site Cardiac Surgery Hassan Al Zammar, MD,FESC Consultant & Interventional Cardiologist Head of Cardiology Department European Gaza Hospital Palestine European

More information

FFR Incorporating & Expanding it s use in Clinical Practice

FFR Incorporating & Expanding it s use in Clinical Practice FFR Incorporating & Expanding it s use in Clinical Practice Suleiman Kharabsheh, MD Consultant Invasive Cardiology Assistant professor, Alfaisal Univ. KFHI - KFSHRC Concept of FFR Maximum flow down a vessel

More information

ΑΝΤΙΓΝΩΜΙΕΣ ΣΤΗΝ ΕΠΕΜΒΑΤΙΚΗ ΚΑΡΔΙΟΛΟΓΙΑ:Νόσος στελέχους Αγγειοπλαστική

ΑΝΤΙΓΝΩΜΙΕΣ ΣΤΗΝ ΕΠΕΜΒΑΤΙΚΗ ΚΑΡΔΙΟΛΟΓΙΑ:Νόσος στελέχους Αγγειοπλαστική ΑΝΤΙΓΝΩΜΙΕΣ ΣΤΗΝ ΕΠΕΜΒΑΤΙΚΗ ΚΑΡΔΙΟΛΟΓΙΑ:Νόσος στελέχους Αγγειοπλαστική X. ΓΡΑΪΔΗΣ Επεμβατικός καρδιολόγος, FSCAI Kλινική Euromedica-Κυανούς Σταυρός, Θεσσαλονίκη The Fear factor The two words LEFT MAIN

More information

LCX. President / Director of Cardiology / New Tokyo Hospital

LCX. President / Director of Cardiology / New Tokyo Hospital LCX President / Director of Cardiology / New Tokyo Hospital Professor of Department of Advanced Cardiovascular Medicine: Kumamoto University Consultant / National Cardiovascular Center / Osaka Sunao Nakamura

More information

ESC Guidelines on the Management of Cardiovascular Diseases during Pregnancy

ESC Guidelines on the Management of Cardiovascular Diseases during Pregnancy ESC Guidelines on the Management of Cardiovascular Diseases during Pregnancy Task force on the management of CVD during pregnancy of the ESC Chair: Vera Regitz-Zagrosek, Charite, Berlin None DECLARATION

More information

What do the guidelines say?

What do the guidelines say? Percutaneous coronary intervention in 3-vessel disease and main stem What do the guidelines say? Nothing to disclose Dariusz Dudek Institute of Cardiology, Jagiellonian University Krakow, Poland The European

More information

Clinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective

Clinical Seminar. Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective Clinical Seminar Which Diabetic Patient is a Candidate for Percutaneous Coronary Intervention - European Perspective Stephan Windecker Department of Cardiology Swiss Cardiovascular Center and Clinical

More information

Declaration of conflict of interest NONE

Declaration of conflict of interest NONE Declaration of conflict of interest NONE Claudio Muneretto MD, PhD Director of Division of Cardiac Surgery University of Brescia Medical School Italy Hybrid Chymera Different features and potential advantages

More information

Le# main treatment with Stentys stent. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy

Le# main treatment with Stentys stent. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy Le# main treatment with Stentys stent Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy Disclosure Statement of Financial Interest I, Carlo Briguori DO NOT have a financial interest/ arrangement

More information

CTO Re vascularization in 2013

CTO Re vascularization in 2013 CTO Re vascularization in 2013 Is it safe to use/stent the sub intimal space? Dimitri Karmpaliotis, MD, FACC, FSCAI Interventional Cardiology Piedmont Heart Institute Atlanta, Georgia Dimitri.karmpaliotis@piedmont.org

More information

Chronic Total Occlusions. Stephen Cook, MD Medical Director, Cardiac Catheterization Laboratory Oregon Heart & Vascular Institute

Chronic Total Occlusions. Stephen Cook, MD Medical Director, Cardiac Catheterization Laboratory Oregon Heart & Vascular Institute Chronic Total Occlusions Stephen Cook, MD Medical Director, Cardiac Catheterization Laboratory Oregon Heart & Vascular Institute Financial Disclosures /see -tee-oh / abbr. Med. Chronic Total Occlusion,

More information

Intracoronary Imaging For Complex PCI A Pichard, L Satler, Ron Waksman, I Ben-Dor, W Suddath, N Bernardo, D Harrington.

Intracoronary Imaging For Complex PCI A Pichard, L Satler, Ron Waksman, I Ben-Dor, W Suddath, N Bernardo, D Harrington. Intracoronary Imaging For Complex PCI A Pichard, L Satler, Ron Waksman, I Ben-Dor, W Suddath, N Bernardo, D Harrington. Medstar Washington Hospital Center Washington, DC Conflict of Interest None for this

More information